This week in techniques

Approach

Summary

Licensing status

Publication and contact information

Markers

Fc g-receptor IIc (CD32C; FCGR2C) variants predict responses to vaccines

Human studies suggest expression of CD32C could help predict patient responses to vaccines. CD32C normally contains a termination codon, but 7%-15% of individuals carry a mutation that changes it into a full-length open reading frame. Individuals with this variant expressed CD32C on B cells and were more likely to respond to an anthrax vaccine than patients that did not express the variant. Individuals with the full-length CD32C variant also were more likely to develop the autoimmune disease systemic lupus erythematosus (SLE) than those without the variant. Next steps could include validating the association of the variant with immune responses in additional individuals.

SciBX 7(4); doi:10.1038/scibx.2014.131
Published online Jan. 30, 2014

Patent and licensing status unavailable

Li, X. et al. Sci. Transl. Med.; published online Dec. 18, 2013;
doi:10.1126/scitranslmed.3007097
Contact: Robert P. Kimberly, The University of Alabama at
Birmingham, Ala.
e-mail:

rpk@uab.edu
Contact: Jeffrey C. Edberg, same affiliation as above
e-mail:

jedberg@uab.edu